Cullinan Therapeutics CGEM
NASDAQ CGEM
$11.35 +0.12 (+1.07%)
At close: Nov 11, 2026 · 4:00 PM EST

Cullinan Therapeutics (CGEM) Return on Assets [ROA] (2021 - 2026)

Updated

Cullinan Therapeutics (CGEM) recorded Return on Assets [ROA] of -53.39% in Q2 2026, down 15.80 percentage points from -37.59% a year earlier and down 1.46 percentage points from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Cullinan Therapeutics reported Return on Assets [ROA] of -41.09%, down 10.79 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for three straight years, with a four-year change of -20.39 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -30.30% in FY2024 (-0.63 pp), -29.68% in FY2023 (-51.55 pp), 21.88% in FY2022 (+42.58 pp) and -20.70% in FY2021.
  • The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] in data going back to Q1 2021.
  • On a year-over-year basis, Return on Assets [ROA] has declined for six consecutive quarters, with an average year-over-year change of -9.86 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 33.69 percentage points in Q4 2022, against a drop of 50.22 percentage points in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -51.93% (Q1 2026), -47.16% (Q4 2025) and -43.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Cullinan Therapeutics 722.60 Mn -1.13 Bn - -59.29%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -59.29%
Jun 30, 2026 -53.39%
Mar 31, 2026 -51.93%
Dec 31, 2025 -47.16%
Sep 30, 2025 -43.17%
Jun 30, 2025 -37.59%
Mar 31, 2025 -29.75%
Dec 31, 2024 -26.28%
Sep 30, 2024 -21.81%
Jun 30, 2024 -25.49%
Mar 31, 2024 -28.77%
Dec 31, 2023 -31.69%
Sep 30, 2023 -30.81%
Jun 30, 2023 -27.45%
Mar 31, 2023 11.88%
Dec 31, 2022 18.53%
Sep 30, 2022 15.89%
Jun 30, 2022 19.68%
Mar 31, 2022 -18.70%
Dec 31, 2021 -15.16%
API Access

Cullinan Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CGEM&period=max&api_key=YOUR_API_KEY